Literature DB >> 30363901

Development of the novel fungicide fenpyrazamine.

Norio Kimura1, Masaya Hashizume2, Tomoyuki Kusaba3, Soichi Tanaka4.   

Abstract

Fenpyrazamine is a novel fungicide with an aminopyrazolinone structure developed by Sumitomo Chemical Co., Ltd. Fenpyrazamine has good fungicidal properties, such as high antifungal activity, preventive activity, translaminar activity, inhibition activity in lesion development, and long lasting activity. The target enzyme of fenpyrazamine is 3-keto reductase in the ergosterol biosynthetic pathway. Fenpyrazamine shows high efficacy against gray mold, stem rot, and brown rot in field trials. Formulated products, PROLECTUS® and PIXIO®DF, have been registered since 2012. PROLECTUS® was first launched in Italy in 2012, and PIXIO®DF was launched in Japan in 2014.

Entities:  

Keywords:  3-keto reductase; Botrytis cinerea; Sclerotiniaceae; fenpyrazamine

Year:  2017        PMID: 30363901      PMCID: PMC6183354          DOI: 10.1584/jpestics.J17-01

Source DB:  PubMed          Journal:  J Pestic Sci        ISSN: 1348-589X            Impact factor:   1.519


  2 in total

Review 1.  Mechanisms of resistance to fungicides in field strains of Botrytis cinerea.

Authors:  Pierre Leroux; René Fritz; Danièle Debieu; Catherine Albertini; Catherine Lanen; Jocelyne Bach; Michel Gredt; Florence Chapeland
Journal:  Pest Manag Sci       Date:  2002-09       Impact factor: 4.845

2.  Fungicide-driven evolution and molecular basis of multidrug resistance in field populations of the grey mould fungus Botrytis cinerea.

Authors:  Matthias Kretschmer; Michaela Leroch; Andreas Mosbach; Anne-Sophie Walker; Sabine Fillinger; Dennis Mernke; Henk-Jan Schoonbeek; Jean-Marc Pradier; Pierre Leroux; Maarten A De Waard; Matthias Hahn
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

  2 in total
  2 in total

1.  Development of novel pesticides in the 21st century.

Authors:  Noriharu Umetsu; Yuichi Shirai
Journal:  J Pestic Sci       Date:  2020-05-20       Impact factor: 2.529

2.  Inhibition of SC4MOL and HSD17B7 shifts cellular sterol composition and promotes oligodendrocyte formation.

Authors:  Matthew J Pleshinger; Ryan M Friedrich; Zita Hubler; Adrianna M Rivera-León; Farrah Gao; David Yan; Joel L Sax; Ramya Srinivasan; Ilya Bederman; H Elizabeth Shick; Paul J Tesar; Drew J Adams
Journal:  RSC Chem Biol       Date:  2021-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.